Byotrol plc
("Byotrol" or the "Company")
PDMR Dealing
Byotrol plc (AIM: BYOT), the developer of anti-microbial hygiene technologies, announces that on 27 January 2022, Vivan Pinto, a PDMR of the Company, purchased 100,000 ordinary shares of 0.25p each ("Ordinary Shares") at an average price of 5.24p per Ordinary Share (the "Purchase"). Due to an administrative oversight the Purchase was not announced at the date of transaction.
Following the Purchase, Vivan Pinto has an interest in 300,000 Ordinary Shares representing 0.07% of the total voting rights of the Company. As announced on 28 July 2022, Vivan Pinto subscribed for convertible loan notes in the Company, which if converted would represent an additional 0.70% of the total voting rights of the Company.
| Byotrol Plc | |
| David Traynor - Chief Executive Officer | +44 (0)1925 742 000 |
| Chris Sedwell - Chief Financial Officer | |
| | |
| finnCap Limited (Nominated Adviser and Broker) | +44 (0)20 7220 0500 |
| Geoff Nash / James Thompson - Corporate Finance | |
| Richard Chambers - ECM | |
| | |
| Flagstaff Strategic and Investor Communications | +44 (0)20 7129 1474 |
| Tim Thompson/Andrea Seymour/Fergus Mellon
|
|
The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.
Notes to Editors:
Byotrol plc (BYOT.L), quoted on AIM, is a leading infection prevention and control company, operating globally in the animal health, human health, facilities management, and consumer sectors.
Byotrol develops unique antimicrobial technologies for use on surfaces, skin and instruments, which it then commercialises through market-leading distribution partners in each sector.
Byotrol's antimicrobial technologies can be licensed for use in leading brands, to significantly improve their product claims, while reassuring consumers and end-users of their efficacy and quality.
Founded in 2005, the Company develops technologies and products with the aim of providing easier, safer and cleaner lives for everyone.
| 1. | Details of the person discharging managerial responsibilities/person closely associated | |||||||
| a) | Name: | Vivan Pinto | ||||||
| 2. | Reason for the notification | |||||||
| a) | Position/status: | PDMR | ||||||
| b) | Initial notification/Amendment: | Initial Notification | ||||||
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||
| a) | Name: | Byotrol plc | ||||||
| b) | LEI: | 213800AJMTSTIPA59A34 | ||||||
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||
| a) | Description of the financial instrument, type of instrument: Identification code: | Ordinary shares of 0.25 pence per share GB00B0999995 | ||||||
| b) | Nature of the transaction: | Purchase of Ordinary Shares
| ||||||
| c) | Price(s) and volume(s): |
| ||||||
| d) | Aggregated information: ·Aggregated volume: ·Price:
|
100,000 Ordinary Shares £5,240
| ||||||
| e) | Date of the transaction: | 27 January 2022 | ||||||
| f) | Place of the transaction: | AIM, London Stock Exchange (XLON) | ||||||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.